GT Biopharma, Inc. — Balance Sheet Charts
44 snapshots of history · ending 2021-09-30 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+1329.5% +$5M
$6M
Current Assets↑+4197.5% +$35M
$36M
Cash & Equivalents↑+1014.3% +$4M
$4M
ST Investments
$26M
Receivables↓-100.0% -$40K
$0
Inventory↓-100.0% -$42K
$0
Net PPE
$0
Goodwill
$254M
Intangibles
$0
Total Liabilities↑+63.5% +$12M
$31M
Current Liabilities↓-87.2% -$27M
$4M
Account Payables↑+29.1% +$631K
$3M
Stockholders Equity↑+207.0% +$62M
$32M
Retained Earnings↓-7.8% -$46M
$-635M
Operating Lease ROU Asset↓-100.0% -$110K
$0
Operating Lease Liability↓-100.0% -$120K
$0
Inventory Raw Materials
$0
Inventory WIP
$0
Inventory Finished Goods↓-100.0% -$42K
$0